Clostridium perfringens phospholipase C-induced platelet/leukocyte interactions impede neutrophil diapedesis.
Clostridium perfringens gas gangrene is a fulminant necrotizing infection in which inflammatory cells are notably absent from infected tissues but are often massed within adjacent vessels. It has been shown that C. perfringens phospholipase C (PLC) stimulates formation of large intravascular platelet/leukocyte complexes and that PLC-induced activation of platelet gpIIbIIIa plays a major role. In vivo, such aggregates contribute to microvascular thrombosis and ischaemic necrosis of tissue. However, the effects of adherent platelets on neutrophil diapedesis have not been established. The present work investigated (1) the contribution of platelet P-selectin (CD62P) to PLC-induced cellular complex formation and (2) the effects of platelet adhesion on neutrophil diapedesis. The effects of anti-gpIIbIIIa and anti-CD62P strategies on PLC-induced complex formation were measured by flow cytometry and followed by light microscopy. Both platelet gpIIbIIIa and CD62P contributed to the formation of platelet/leukocyte complexes. Specifically, gpIIbIIIa mediated the formation of large platelet/platelet aggregates that were tethered to the leukocyte principally via CD62P. Neutrophil diapedesis, quantified by a transendothelial cell migration assay and visualized by electron microscopy, was significantly reduced (>60%) by the adherence of large platelet aggregates. It was concluded that the absence of a tissue inflammatory response in C. perfringens gas gangrene is due, in part, to impaired neutrophil mobility caused by large aggregates of adherent platelets induced by PLC. Further, an adjunctive immunotherapeutic strategy targeting both gpIIbIIIa and CD62P may improve the tissue inflammatory response, prevent vascular occlusion, maintain tissue viability, and reduce the need for radical amputation in patients with clostridial gas gangrene.
University of Idaho, Moscow, ID, USA.|Infectious Diseases Section, Veterans Affairs Medical Center, Building 45, 500 West Fort Street, Boise, ID 83702, USA.
A E
AE
Bryant
University of Idaho, Moscow, ID, USA.|Infectious Diseases Section, Veterans Affairs Medical Center, Building 45, 500 West Fort Street, Boise, ID 83702, USA.
C R
CR
Bayer
University of Idaho, Moscow, ID, USA.
M J
MJ
Aldape
Infectious Diseases Section, Veterans Affairs Medical Center, Building 45, 500 West Fort Street, Boise, ID 83702, USA.
R J
RJ
Wallace
Defence Science and Technology Laboratory, Porton Down, Salisbury, UK.
R W
RW
Titball
University of Washington, Seattle, WA, USA.|Infectious Diseases Section, Veterans Affairs Medical Center, Building 45, 500 West Fort Street, Boise, ID 83702, USA.
D L
DL
Stevens
D001792:Blood Platelets / Q000502:physiology*; D002464:Cell Migration Inhibition; D002465:Cell Movement; D003016:Clostridium perfringens / Q000201:enzymology* / Q000472:pathogenicity; D005434:Flow Cytometry; D005738:Gas Gangrene / Q000382:microbiology / Q000473:pathology; D006801:Humans; D008854:Microscopy, Electron; D008954:Models, Biological; D009504:Neutrophils / Q000502:physiology*; D019007:P-Selectin / Q000378:metabolism; D010974:Platelet Aggregation; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000378:metabolism; D010738:Type C Phospholipases / Q000378:metabolism*
D019007:P-Selectin; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D010738:Type C Phospholipases